HA 14-1
HA 14-1 物理性質(zhì)
- 融點(diǎn) :
- 105 °C
- 比重(密度) :
- 1.480
- 貯蔵溫度 :
- Keep in dark place,Sealed in dry,Store in freezer, under -20°C
- 溶解性:
- DMSO: 26 mg/mL
- 外見 :
- 粉
- 色:
- White to light yellow
- CAS データベース:
- 65673-63-4
| メーカー |
製品番號 |
製品説明 |
CAS番號 |
包裝 |
価格 |
更新時(shí)間 |
購入 |
|
富士フイルム和光純薬株式會(huì)社(wako)
|
W01TOC1541 |
HA14-1 |
65673-63-4 |
5mg |
￥25000 |
2021-03-23 |
購入 |
|
富士フイルム和光純薬株式會(huì)社(wako)
|
W01TOC1541 |
HA14-1 |
65673-63-4 |
25mg |
￥95000 |
2021-03-23 |
購入 |
|
Sigma-Aldrich Japan
|
H8787 |
≥95% (CHN/NMR), powder
HA 14-1 ≥95% (CHN/NMR), powder |
65673-63-4 |
5mg |
￥14720 |
2021-03-23 |
購入 |
|
Sigma-Aldrich Japan
|
H8787 |
≥95% (CHN/NMR), powder
HA 14-1 ≥95% (CHN/NMR), powder |
65673-63-4 |
25mg |
￥82900 |
2018-12-25 |
購入 |
HA 14-1 化學(xué)特性,用途語,生産方法
使用
HA14-1 is a cell-permeable, nonpeptidic Bcl-2 inhibitor.
生物活性
Cell-permeable inhibitor of Bcl-2 protein (IC 50 ~ 9 μ M); acts by binding to the surface pocket. Disrupts Bax/Bcl-2 interaction and induces apoptosis of tumor cells.
Biochem/physiol Actions
HA 14-1 is a nonpeptide apoptosis inducer; Bcl-2 antagonist.
HA 14-1 上流と下流の製品情報(bào)
原材料
準(zhǔn)備製品
HA 14-1 生産企業(yè)
Global( 125)Suppliers
HA 14-1 スペクトルデータ(1HNMR、MS)
65673-63-4(HA 14-1)キーワード:
- 65673-63-4
- 2-Amino-6-bromo-alpha-cyano-3-(ethoxycarbonyl)-(4H)-1-benzopyrane-4-aceticacidethylester
- ethyl 6-broMo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chroMene-3-carboxylate
- 2-Amino-6-bromo-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetic acid ethyl ester, Ethyl [2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)]-4H-chromene-3-carboxylate
- [Ethyl 2-amino-6-bromo-4-(1cyano-2-ethoxy-2-oxoethyl)-4H-chromene3-3carboxylate], Ethyl [2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)]-4H-chromene-3-carboxylate
- 2-Amino-6-bromo-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-aceticacidethylester
- 2-Amino-6-bromo-alpha-cyano-3-(ethoxycarbonyl)-(alphaR,4R)-rel-4H-1-benzopyran-4-acetic acid ethyl ester
- Ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-1-benzopyran-3-carboxylate 97%
- HA 14-1, Ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate, 2-[2-Amino-6-bromo-3-(ethoxycarbonyl)-4H-chromen-4-yl]-3-ethoxy-3-oxopropanenitrile
- (R)-ethyl 2-amino-6-bromo-4-((R)-1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate
- 2-Amino-6-bromo-alpha-cyano-3-(ethoxycarbonyl)-(alphaR,4R)-rel-4H-1-benzopyran-4-acetic acid ethyl ester HA 14-1
- HA 14-1 2-Amino-6-bromo-alpha-cyano-3-(ethoxycarbonyl)-(alphaR,4R)-rel-4H-1-benzopyran-4-acetic acid ethyl ester
- [Ethyl 2-amino-6-bromo-4-(1cyano-2-ethoxy-2-oxoethyl)-4H-chromene3-3carboxylate]
- Ethyl2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-1-benzopyran-3-carboxylate97%
- HA14-1;HA-14-1; HA 14-1
- ethyl (4S)-2-amino-6-bromo-4-[(R)-cyano-ethoxycarbonyl-methyl]-4H-chromene-3-carboxylate
- ETHYL [2-AMINO-6-BROMO-4-(1-CYANO-2-ETHOXY-2-OXOETHYL)]-4H-CHROMENE-3-CARBOXYLATE
- 2-AMINO-6-BROMO-ALPHA-CYANO-3-(ETHOXYCARBONYL)-4H-1-BENZOPYRAN-4-ACETIC ACID ETHYL ESTER
- HA14-1
- Ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-1-benzopyran-3-carboxylate
- CS-392
- 4H-1-Benzopyran-4-acetic acid, 2-amino-6-bromo-α-cyano-3-(ethoxycarbonyl)-, ethyl ester, (αR,4R)-rel-
- HA14-1 USP/EP/BP
- rel-(R)-Ethyl 2-amino-6-bromo-4-((R)-1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate(relative)
- rel-Ethyl (αR,4R)-2-amino-6-bromo-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-acetate
- HA14-1/HA141
- 6-ブロモ-2-アミノ-4-(1-シアノ-2-オキソ-2-エトキシエチル)-4H-1-ベンゾピラン-3-カルボン酸エチル
- HA 14-1
- エチル 2-アミノ-6-ブロモ-4-(1-シアノ-2-エトキシ-2-オキソエチル)-4H-クロメン-3-カルボキシラート
- 2-アミノ-4-(1-シアノ-2-エトキシ-2-オキソエチル)-6-ブロモ-γ-クロメン-3-カルボン酸エチル
- 2-[2-アミノ-6-ブロモ-3-(エトキシカルボニル)-4H-1-ベンゾピラン-4-イル]-2-シアノ酢酸エチル
- α-シアノ-2-アミノ-3-(エトキシカルボニル)-6-ブロモ-4H-1-ベンゾピラン-4-酢酸エチル
- 2-アミノ-4-[エトキシカルボニル(シアノ)メチル]6-ブロモ-γ-クロメン-3-カルボン酸エチル